Financial insights of RXST

MyFinsight

For the quarter ending 2025-09-30, RXST made $30,340,000 in revenue. -$9,639,000 in net income. Net profit margin of -31.77%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Sales	30,340,000	33,637,000	37,895,000	-
Cost of sales	6,113,000	8,447,000	9,566,000	-
Gross profit	24,227,000	25,190,000	28,329,000	24,574,333.333
Selling, general and administrative	27,345,000	28,976,000	28,636,000	25,275,333.333
Research and development	9,060,000	10,217,000	10,367,000	8,509,666.667
Total operating expenses	36,405,000	39,193,000	39,003,000	33,785,000
Loss from operations	-12,178,000	-14,003,000	-10,674,000	-9,210,666.667
Interest expense	4,000	5,000	6,000	5,333.333
Interest and other income	2,376,000	2,254,000	2,508,000	2,189,333.333
Loss before income taxes	-9,806,000	-11,754,000	-8,172,000	-7,026,666.667
Income tax expense	10,000	32,000	18,000	12,333.333
Net loss	-9,816,000	-11,786,000	-8,190,000	-7,039,000
Unrealized gain (loss) on short-term investments	178,000	-146,000	-157,000	-151,000
Foreign currency translation (loss) gain	-1,000	14,000	6,000	-5,000
Total other comprehensive loss	177,000	-132,000	-151,000	-156,000
Comprehensive loss	-9,639,000	-11,918,000	-8,341,000	-7,195,000

Earnings per share, basic	-0.24	-0.29	-0.2	-0.183
Earnings per share, diluted, total	-0.24	-0.29	-0.2	-0.183
Weighted average number of shares outstanding, basic, total	40,965,219	40,743,786	40,509,646	-306,965
Weighted average number of shares outstanding, diluted	40,965,219	40,743,786	40,509,646	-306,965